New Cousteau-Linked...
AngioDynamics Inc. (ANGO: NASDAQ)
$11.90 -0.14 | -1.16%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 11.90 |
| 52 Week High | 16.39 |
| 52 Week Low | 11.35 |
| Avg. Daily Vol. (Mil) | 0.12 |
| Beta (3 year) | 0.48 |
| Share Related Items | |
| Mkt Cap (Mil) | 299.82 |
| Shares Out (Mil) | 25.20 |
| Float (Mil) | 24.69 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.80 |
| Current Ratio | 7.20 |
| LT Debt/ Equity | 0.01 |
| Total Debt / Equity | 0.02 |
| Valuation Ratios | |
| Price Earnings | 396.70 |
| Price/Sales | 1.36 |
| Price/Book | 0.73 |
| Price/Cash Flow | 20.60 |
| Per Share Data | |
| Earnings | 0.03 |
| Sales | 8.74 |
| Book Value | 16.33 |
| Cash Flow | 0.58 |
| Business Summary | |
|---|---|
| AngioDynamics, Inc. provides medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease, and local oncology therapy options for treating cancer. | |
| General Information | |
| 603 Queensbury Avenue
Queensbury, NY 12804 |
|
| www.angiodynamics.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 722 | |
| CEO: Mr. Joseph M. Devivo | |
| Short Interest | |
| Current Month (Mil) | 1.46 |
| Previous Month (Mil) | 1.44 |
| Short Interest Ratio (Days) | 17.60 |
| Management Effectiveness | |
| Return on Equity | 0.30 |
| Return on Assets | 0.20 |
| Return on Investments | 0.30 |
| Profitability | |
| Gross Margin | 59.60 |
| EBIT Margin | 0.40 |
| Profit Margin | 0.50 |
Portfolios with ANGO
- Portfolio NameUser Type
- UserMedical devices M&A
- ContributorEarnings Short Squeeze Play...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- UserLast Day of the JPMorgan He...
- UserDrewski2 Portfolio 1
- Userwafessler Portfolio 1
- UserRPavlovic Portfolio 1
- UserGluck Portfolio 1
- Userchappervester Portfolio 1
Latest ANGO Headlines from TheStreet
- 5 Stocks That Make Prime Acquisition Targets 05.22.12 | 08:05 am
- AngioDynamics' CEO Discusses Q3 2012 Results - Earnings Call Transcript 04.04.12 | 08:04 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 03.09.12 | 04:03 am
- AngioDynamics Inc. Presents At The 30th Annual JPMorgan Chase Healthcare Conference, Jan-12-2012 10:30 AM 01.12.12 | 08:01 pm
- AngioDynamics Inc. Stock Upgraded (ANGO) 01.09.12 | 05:01 am
- AngioDynamics' CEO Discusses Q2 2012 Results - Earnings Call Transcript 01.05.12 | 10:01 pm
- AngioDynamics Inc. Stock Downgraded (ANGO) 11.29.11 | 06:11 am
- AngioDynamics Inc. Stock Upgraded (ANGO) 10.26.11 | 07:10 am
- AngioDynamics' CEO Discusses Q1 2012 Results - Earnings Call Transcript 10.06.11 | 09:10 pm
- 5 Earnings Stocks to Squeeze the Bears 10.04.11 | 01:10 pm
Press Releases for ANGO
- NanoKnife® System Clinical Experience Featured At Society Of Surgical Oncology Conference - Business Wire 04.02.12 | 06:04 am
- Five Oral Presentations On Clinical Experience With NanoKnife® System Featured At Society Of Interventional Radiology Conference - Business Wire 03.29.12 | 06:03 am
- AngioDynamics Establishes Strategic Relationship With Microsulis Medical Ltd. - Business Wire 03.26.12 | 06:03 am
- Scott Solano To Depart AngioDynamics - Business Wire 09.22.11 | 04:09 pm
- AngioDynamics Names Joseph M. DeVivo President And CEO - Business Wire 08.16.11 | 07:08 am
- AngioDynamics Reports Fiscal 2011 Fourth Quarter And Full Year Financial Results - Business Wire 07.14.11 | 04:07 pm
- AngioDynamics To Report Fiscal 2011 Fourth Quarter And Full Year Financial Results And Hold Conference Call On July 14, 2011 - Business Wire 07.05.11 | 06:07 am
- AngioDynamics Reports Preliminary Fiscal 2011 Fourth Quarter Financial Results And Corporate Developments - Business Wire 06.13.11 | 04:06 pm
- AngioDynamics Launches VenaCure® 1470nm Laser For Treatment Of Varicose Veins - Business Wire 05.31.11 | 06:05 am
- AngioDynamics Expands VenaCure EVLT® System For Varicose Veins With Longer 90 Cm Kit - Business Wire 05.26.11 | 06:05 am
Partner Headlines for ANGO
- The Zacks Analyst Blog Highlights: AngioDynamics, J.P. Morgan, Bank of America, KeyCorp and CR Bard - Press Releases - Zacks 05.24.12 | 09:05 am
- ANGO Mixed, Adjusts View - Analyst Blog - Zacks 04.05.12 | 09:04 am
- 6 Insider Stock Picks Rated Buy By Canaccord Genuity - Seeking Alpha 02.10.12 | 05:02 pm
- AngioDynamics Cuts View on Recall - Analyst Blog - Zacks 01.27.12 | 07:01 pm
- AngioDynamics Beats, Tweaks View - Analyst Blog - Zacks 01.06.12 | 09:01 am
- November's Low Price To Book Stocks Vs. Bankruptcy Risks - Seeking Alpha 11.04.11 | 08:11 am
- BSD Promotes Hyperthermia Tech - Analyst Blog - Zacks 10.31.11 | 07:10 pm
- Bard's 3Q Mixed, Buying Medivance - Analyst Blog - Zacks 10.26.11 | 09:10 am
- AngioDynamics Trades Lower on Q1 Earnings Results - Benzinga 10.06.11 | 04:10 pm
- Company News for June 16, 2011 - Corporate Summary - Zacks 06.16.11 | 10:06 am





